Distribution of immunochemically defined apoB-containing lipoprotein subclasses in T1D

Taskinen, 1990, Hyperlipidemia in diabetes, Baillieres Clin. Endocrinol. Metab., 4, 743, 10.1016/S0950-351X(05)80078-3 Bagdade, 1989, Whole plasma and high density lipoprotein subfraction surface lipid composition in insulin-dependent diabetic males, Diabetes, 319898, 1226, 10.2337/diabetes.38.10.1226 Bagdade, 1990, Effects of omega-3 fish oils on plasma lipids, lipoprotein composition, and post-heparin lipase in women with insulin-dependent diabetes, Diabetes, 39, 426, 10.2337/diabetes.39.4.426 Bagdade, 1990, Persistent abnormalities in lipoprotein composition in noninsulin-dependent diabetes following intensive insulin therapy, Arteriosclerosis, 10, 232, 10.1161/01.ATV.10.2.232 Alaupovic, 1996, The significance of apolipoproteins for structure, function and classification of plasma lipoproteins, 32 Alaupovic, 1991, Apolipoprotein composition as the basis for classifying plasma lipoproteins. Characterization of ApoA- and ApoB-containing lipoprotein families, Prog. Lipid Res., 30, 105, 10.1016/0163-7827(91)90008-S Gervaise, 2000, Triglycerides, apoC3 and LpB:C3 and cardiovascular risk in Type II diabetes, Diabetologia, 43, 703, 10.1007/s001250051366 Klein, 2005, Garvey WT; DCCT/EDIC Research Group. Apolipoprotein C-III protein concentration and gene polymorphisms in Type 1 diabetes: association with micro vascular disease complication in the DCCT/EDIC cohort, J. Diabetes Complications, 19, 18, 10.1016/j.jdiacomp.2004.04.005 Friedewald, 1972, Estimation of the concentration of low-density lipoprotein cholesterol in plasma without use of the preparative ultracentrifuge, Clin. Chem., 18, 499, 10.1093/clinchem/18.6.499 Curry, 1976, Determination of apolipoprotein A and its constitutive A-I and A-II polypeptides by separate electro immunoassays, Clin. Chem., 22, 315, 10.1093/clinchem/22.3.315 Curry, 1978, Electro immunoassay, radioimmunoassay, and radial immunodiffusion assay evaluated for quantification of human apolipoprotein B, Clin. Chem., 24, 280, 10.1093/clinchem/24.2.280 Curry, 1980, Quantitative determination of human apolipoprotein C-III by electro immunoassays, Biochem. Biophys. Acta, 617, 505, 10.1016/0005-2760(80)90016-8 Curry, 1976, Determination of human apolipoprotein E by electro immunoassay, Biochem. Biophys. Acta, 439, 413 Hilpert, 2007, Postprandial effect of n-3 polyunsaturated fatty acids on apolipoprotein B-containing lipoproteins and vascular reactivity in type 2 diabetes, Am. J. Clin. Nutr., 85, 369, 10.1093/ajcn/85.2.369 Morton, 1988, Free cholesterol is a potent regulator of lipid transfer function, J. Biol. Chem., 263, 12235, 10.1016/S0021-9258(18)37745-7 Bagdade, 1991, Accelerated cholesteryl ester transfer in patients with insulin-dependent diabetes mellitus, Eur. J. Clin. Invest., 21, 161, 10.1111/j.1365-2362.1991.tb01805.x Dullaart, 1989, Increased cholesteryl ester transfer activity in complicated type I (insulin-dependent) diabetes mellitus: its relationship with serum lipids, Diabetologia, 21, 14 Koren, 1994, Differential atherogenicity of complex apoB-containing lipoprotein particles, Atherosclerosis, 109, 217, 10.1016/0021-9150(94)93874-1 Blankenhorn, 1990, Prediction of angiographic change in native human coronary arteries and aortocoronary bypass grafts-lipid and nonlipid factors, Circulation, 81, 470, 10.1161/01.CIR.81.2.470 Alaupovic, 1997, The role of triglyceride-rich lipoprotein families in the progression of atherosclerotic lesions as determined by sequential coronary angiography from a controlled clinical trial, Arterioscler. Thromb. Vasc. Biol., 17, 715, 10.1161/01.ATV.17.4.715 Hodis, 1994, Triglyceride- and cholesterol-rich lipoproteins have a different effect on mild to moderate/severe lesion progression as assessed by quantitative coronary angiography in a controlled trial of Lovastatin, Circulation, 90, 42, 10.1161/01.CIR.90.1.42 Sacks, 2000, VLDL Apolipoproteins B, C-III, and E, and risk of recurrent coronary events in the cholesterol and recurrent events (CARE) Trial, Circulation, 102, 1886, 10.1161/01.CIR.102.16.1886 Lee, 2003, LDL-containing apoprotein C-III is an independent risk factor for coronary events in diabetic patients, Arterioscler. Thromb. Vasc. Biol., 23, 853, 10.1161/01.ATV.0000066131.01313.EB Kawakami, 2006, Apolipoprotein CIII in Apolipoprotein B lipoproteins enhances the adhesion of human monocytic cells to endothelial cells, Circulation, 113, 691, 10.1161/CIRCULATIONAHA.105.591743 Kawakami, 2006, Apolipoprotein CIII induces expression of vascular cell adhesion molecule-1 in vascular endothelial cells and increases adhesion of monocytic cells, Circulation, 114, 681, 10.1161/CIRCULATIONAHA.106.622514 Jutti-Berggren, 2004, Apoliprotein CIII promotes Ca2+-dependent B cell death in type 1 diabetes, Proc. Nat. Acad. Sci., 101, 10090, 10.1073/pnas.0403551101 Alaupovic, 1992, Identification of ApoB-containing lipoprotein families in NIDDM, Diabetes, 41, 18, 10.2337/diab.41.2.S18 Mazzone, 1984, In vivo stimulation of LDL degradation by insulin, Diabetes, 33, 333, 10.2337/diabetes.33.4.333 Lillis, 2005, Beyond endocytosis: LRP function in cell migration, proliferation and vascular permeability, J. Thromb. Haemost., 3, 1884, 10.1111/j.1538-7836.2005.01371.x Descamps, 1993, Insulin stimulates receptor-mediated uptake of ApoE-enriched lipoproteins and activated α2-macroglobulin in adipocytes, J. Biol. Chem., 268, 974, 10.1016/S0021-9258(18)54029-1 Guerci, 1996, Intraperitoneal insulin infusion improves the depletion in choline-containing phospholipids of lipoprotein B particles in type 1 diabetic patients, Metabolism, 45, 430, 10.1016/S0026-0495(96)90215-2 Bagdade, 1994, Intraperitoneal insulin therapy corrects abnormalities in cholesteryl ester transfer and lipoprotein lipase in insulin-dependent diabetes mellitus, Arterioscler. Thromb., 14, 1933, 10.1161/01.ATV.14.12.1933 Duvillard, 2005, Comparison of apolipoprotein B100 metabolism between continuous subcutaneous and intraperitoneal insulin therapy in type 1 diabetes, J. Clin. Endocrinol. Metab., 90, 5761, 10.1210/jc.2005-0989 Hussain, 1996, Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM, Diabetologia, 39, 60, 10.1007/BF00400414 Targer, 2001, Elevated levels of interleukin-6 in young adults with type 1 diabetes without clinical evidence of microvascular and macrovascular complications, Diabetes Care, 24, 956, 10.2337/diacare.24.5.956 Ruan, 2006, Mechanisms of dysregulation of low-density lipoprotein receptor expression in vascular smooth muscle cells by inflammatory cytokines, Arterioscler. Thromb. Vasc. Biol., 26, 1150, 10.1161/01.ATV.0000217957.93135.c2 Khovidunkit, 2004, Effects of infection and inflammation on lipid and lipoprotein metabolism: mechanisms and consequences to the host, J. Lipid Res., 45, 1169, 10.1194/jlr.R300019-JLR200